A reduced density of HIF-1α+CD8+ cells in the TC of the primary lesion is significantly associated with postoperative recurrence in N0-stage NSCLC patients and may serve as a potential immunological marker for postoperative risk stratification. This evidence concerns the gene HIF1A and non-small cell lung carcinoma.